Form 8-K Avidity Biosciences, For: Jun 10

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. SPOT
6. BYD
7. WCN
8. SPY
9. BE
10. FIX

Go back to Form 8-K Avidity Biosciences, For: Jun 10

Avidity Biosciences (RNA) PT Raised to $45 at BofA Securities

June 13, 2024 5:17 AM EDT

BofA Securities analyst Geoff Meacham raised the price target on Avidity Biosciences (NASDAQ: RNA) to $45.00 (from $40.00) while maintaining a Buy rating.

The analyst comments "This morning, Avidity reported compelling biomarker (>50% reduction in DUX4 related gene panels) and functional strength improvement data in FSHD (a rare muscle disorder) patients treated with... More